Junying Chen

2.4k total citations
99 papers, 1.7k citations indexed

About

Junying Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Junying Chen has authored 99 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 25 papers in Cancer Research and 24 papers in Oncology. Recurrent topics in Junying Chen's work include MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (11 papers) and Circular RNAs in diseases (11 papers). Junying Chen is often cited by papers focused on MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (11 papers) and Circular RNAs in diseases (11 papers). Junying Chen collaborates with scholars based in China, United States and Singapore. Junying Chen's co-authors include Desheng Yao, Nan Ding, Shan Zhao, Li Li, Fei Ren, Tong Xiang, Haixia Long, Yaqiong Pei, Zhilu Ai and Wei Zhu and has published in prestigious journals such as Nature Communications, PLoS ONE and Hepatology.

In The Last Decade

Junying Chen

95 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junying Chen China 23 824 645 253 178 172 99 1.7k
Ning Cui China 17 622 0.8× 390 0.6× 216 0.9× 186 1.0× 182 1.1× 52 1.6k
Wu Li China 26 966 1.2× 423 0.7× 469 1.9× 167 0.9× 253 1.5× 89 2.0k
Jae‐Young Kim South Korea 24 1.2k 1.5× 303 0.5× 153 0.6× 141 0.8× 243 1.4× 124 2.1k
Hongbin Li China 24 759 0.9× 544 0.8× 180 0.7× 207 1.2× 111 0.6× 87 1.6k
Márta Széll Hungary 27 972 1.2× 485 0.8× 237 0.9× 245 1.4× 554 3.2× 125 2.4k
Lei Geng China 22 571 0.7× 315 0.5× 383 1.5× 288 1.6× 318 1.8× 80 1.7k
Maria Musumeci Italy 19 1.2k 1.5× 870 1.3× 131 0.5× 88 0.5× 256 1.5× 49 1.9k
Steffen Schubert Germany 23 1.4k 1.7× 411 0.6× 131 0.5× 123 0.7× 200 1.2× 78 2.1k
Rosalío Ramos‐Payán Mexico 18 453 0.5× 283 0.4× 153 0.6× 252 1.4× 272 1.6× 76 1.3k
Xiaofeng Zheng China 20 661 0.8× 225 0.3× 138 0.5× 74 0.4× 197 1.1× 72 1.4k

Countries citing papers authored by Junying Chen

Since Specialization
Citations

This map shows the geographic impact of Junying Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junying Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junying Chen more than expected).

Fields of papers citing papers by Junying Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junying Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junying Chen. The network helps show where Junying Chen may publish in the future.

Co-authorship network of co-authors of Junying Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Junying Chen. A scholar is included among the top collaborators of Junying Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junying Chen. Junying Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Junying, Ruilong Lan, Zeng Wang, et al.. (2025). A CCR5 antagonist enhances the radiosensitivity of hepatocarcinoma in a mouse model. Journal of Radiation Research. 66(4). 396–407.
2.
Tan, Lianmei, Tao Yin, Handan Xiang, et al.. (2024). Aberrant cytoplasmic expression of UHRF1 restrains the MHC-I-mediated anti-tumor immune response. Nature Communications. 15(1). 8569–8569. 10 indexed citations
3.
Pei, Xinyu, et al.. (2024). Stability-enhanced (Cu-, Zn-)MOFs via (Cu, Zn)S composite strategy: A promising approach for oil-water separation. Surface and Coatings Technology. 494. 131316–131316. 4 indexed citations
4.
Li, Ling, et al.. (2023). Identification of a copper metabolism‐related gene signature for predicting prognosis and immune response in glioma. Cancer Medicine. 12(8). 10123–10137. 11 indexed citations
6.
7.
He, Yan, et al.. (2022). Determination of modafinil in rat plasma by UPLC-MS/MS and a study of its pharmacokinetics and bioavailability. Acta Chromatographica. 35(2). 187–192. 3 indexed citations
8.
Qin, Xianyan, Li‐Hua Pan, Tao Chen, et al.. (2022). Inflammation-responsive nanoparticles suppress lymphatic clearance for prolonged arthritis therapy. Journal of Controlled Release. 352. 700–711. 25 indexed citations
9.
Li, Tingting, Yun Shu, Juan Zhang, et al.. (2022). The whole‐genome sequencing of prevalent DENV‐1 strains during the largest dengue virus outbreak in Xishuangbanna Dai autonomous prefecture in 2019. Journal of Medical Virology. 95(1). e28115–e28115. 2 indexed citations
10.
Jia, Fan, Li Zhang, Yue Pan, et al.. (2022). Functional analysis of differentially expressed long non-coding RNAs in DENV-3 infection and antibody-dependent enhancement of viral infection. Virus Research. 319. 198883–198883. 2 indexed citations
11.
Liu, Fang, et al.. (2021). Can Tai Chi Improve Cognitive Function? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The Journal of Alternative and Complementary Medicine. 27(12). 1070–1083. 32 indexed citations
12.
Zou, Jianyong, Junying Chen, Xuan Xie, et al.. (2019). Hepatitis B Virus Infection is a Prognostic Biomarker for Better Survival in Operable Esophageal Cancer: Analysis of 2,004 Patients from an Endemic Area in China. Cancer Epidemiology Biomarkers & Prevention. 28(6). 1028–1035. 11 indexed citations
13.
Han, Yanyan, et al.. (2018). Genetic diversity and haplotype analysis of Guizhou Miao identified with 19 X-chromosomal short tandem repeats. International Journal of Legal Medicine. 133(1). 99–101. 26 indexed citations
15.
Huang, Fei, et al.. (2018). Hypoxia induced δ-Catenin to enhance mice hepatocellular carcinoma progression via Wnt signaling. Experimental Cell Research. 374(1). 94–103. 13 indexed citations
16.
Liu, Qianwen, Junying Chen, Jing Wen, et al.. (2017). Comparison of right- and left-approach esophagectomy for elderly patients with operable thoracic esophageal squamous cell carcinoma: a propensity matched study. Journal of Thoracic Disease. 9(7). 1883–1890. 12 indexed citations
17.
Pan, Yue, Xiaohui Wang, Junying Chen, et al.. (2015). [Genomic characteristics of an echovirus 20 strain (KM/EV20/2010) isolated in Kunming, Yunnan, China].. PubMed. 36(5). 501–5. 2 indexed citations
18.
Zhao, Shan, Desheng Yao, Junying Chen, Nan Ding, & Fei Ren. (2015). MiR-20a Promotes Cervical Cancer Proliferation and Metastasis In Vitro and In Vivo. PLoS ONE. 10(3). e0120905–e0120905. 84 indexed citations
19.
Zhao, Shan, Desheng Yao, Junying Chen, & Nan Ding. (2013). Circulating miRNA-20a and miRNA-203 for Screening Lymph Node Metastasis in Early Stage Cervical Cancer. Genetic Testing and Molecular Biomarkers. 17(8). 631–636. 73 indexed citations
20.
Chen, Junying, et al.. (2009). Rice canopy biochemical concentration retrievals based on Hyperion data. National Remote Sensing Bulletin. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026